MedPath

Evaluating theophylline efficacy in ADCY5-related disease Dyskinesia - a prospective study

Recruiting
Conditions
G24.8
Other dystonia
Registration Number
DRKS00034720
Lead Sponsor
Medizinische Fakultät Leipzig
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Consent of the patients or guardians to the analysis of the anonymized data

Exclusion Criteria

no proof of ADCY5 mutation

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Observation of therapeutic effects of theophylline on the symptoms of ADCY5 dyskinesia<br><br>WHAT: Influence of theophylline on symptoms. <br>WHEN: at a time chosen by the patient or family within the recruitment window. There is therefore no specification of a specific theophylline dose or a specific clinical condition. HOW: using a questionnaire: here a list of typical ADCY5-associated symptoms is offered and explained. The effects of theophylline are asked about using a Likert scale
Secondary Outcome Measures
NameTimeMethod
Tolerance of theophylline<br><br>The questionnaire contains questions about adverse drug reactions (ADRs), which are answered by the patient/family. These ADRs are related to the indicated dose of theophylline.
© Copyright 2025. All Rights Reserved by MedPath